SCHEMBL3408224

SCHEMBL3408224

O=C(O)c1c(=O)[nH]n2c(=O)c3c([nH]c12)CCCC3

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.50
TDP1 Q9NUW8 5/20 0.50
L3MBTL1 Q9Y468 4/20 0.50
KMT2A Q03164 9/20 0.45
MEN1 O00255 8/20 0.45
POLB P06746 6/20 0.45
HPGD P15428 5/20 0.45
LMNA P02545 5/20 0.45
HTT P42858 3/20 0.45
KDM4E B2RXH2 3/20 0.45
CRHBP P24387 2/20 0.45
CRHR2 Q13324 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
BLM P54132 2/20 0.45
CTDSP1 Q9GZU7 2/20 0.45
ALPL P05186 1/20 0.45
ALPI P09923 1/20 0.45
GAA P10253 1/20 0.45
ALPG P10696 1/20 0.45
HKDC1 Q2TB90 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3411734 0.80 LMNA (0.58) MAPTTDP1L3MBTL1KMT2AMEN1
SCHEMBL3410031 0.80 MAPT (0.52) MAPTTDP1L3MBTL1KMT2AMEN1
SCHEMBL3407592 0.78 MAPT (0.50) MAPTTDP1L3MBTL1KMT2AMEN1
SCHEMBL3408312 0.78 TDP1 (0.49) MAPTTDP1L3MBTL1KMT2AMEN1
SCHEMBL3409245 0.77 MEN1 (0.50) MAPTTDP1L3MBTL1KMT2AMEN1
SCHEMBL3409992 0.77 POLB (0.50) MAPTTDP1L3MBTL1KMT2AMEN1
SCHEMBL3411680 0.76 MAPT (0.47) MAPTTDP1L3MBTL1KMT2AMEN1
SCHEMBL3411768 0.74 MAPT (0.46) MAPTTDP1L3MBTL1KMT2AMEN1
SCHEMBL3411765 0.74 MAPT (0.43) MAPTTDP1L3MBTL1KMT2AMEN1
SCHEMBL3411549 0.73 NPC1 (0.49) MAPTTDP1L3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2264035-A1 Glycine B antagonists Merz Pharma GmbH & Co. KGaA (DE) 2010-12-22 EP claimed
EP-2264035-A1 Glycine B antagonists Merz Pharma GmbH & Co. KGaA (DE) 2010-12-22 EP disclosed